Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Status unconfirmed · Early Phase 1

Conditions studied: Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer, Non-melanoma Skin Cancer

In brief

Randomized comparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment of biopsy proven squamous cell carcinomas of the skin in otherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Key facts

Study ID
NCT05932511
Run by
Center for Biomedical Research, Inc.
People needed
15
Starts
2023-06-12
Expected to finish
2024-12-31
Last updated by the study team
2023-08-30

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.